Panadol®
Sponsors
Sinew Pharma Inc.
Conditions
Acetaminophen ToxicityHepatitisPharmacology
Unknown Phase
A Randomized, Single-blind, Parallel Group and Multiple - Dose Design Study
CompletedNCT03451487
Start: 2022-05-19End: 2022-12-31Updated: 2023-07-18
A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers
RecruitingNCT05563961
Start: 2022-10-28End: 2024-12-31Target: 48Updated: 2024-03-27